Found 8 matching trials
CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1) PHASE1 The purpose of this study is to evaluate a pharmacokinetic drug interaction...
Show More Location
Chonbuk National University Hospital
Learn More & Join Trial
Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety PHASE4 Diabetes is the most frequently occurring chronic disease along with obesit...
Show More Location
Seoul National University Bundang Hospital
Learn More & Join Trial
CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1) PHASE1 The purpose of this study is to evaluate a pharmacokinetic drug interaction...
Show More Location
Chonbuk National University Hospital
Learn More & Join Trial
Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus N/A Previous thiazolidinediones (TZDs) have issued various safety concerns incl...
Show More Location
Division of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St Mary's Hospital, College of Medicine, The Catholic University of Korea
Learn More & Join Trial
A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers PHASE1 This study is a randomized, open-label, single dose, 2-way crossover study ...
Show More Location
Chonbuk National University Hospital
Learn More & Join Trial
Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State. PHASE1 This is a Randomized, open-label, single oral dosing, two-sequence, and two...
Show More Location
Chung-Ang University Gwangmyeong Hospital
Learn More & Join Trial
A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers PHASE1 This study is a randomized, open-label, single dose, 2-way crossover study ...
Show More Location
Chonbuk National University Hospital
Learn More & Join Trial
A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers PHASE1 This study is a randomized, open-label, single dose, 2-way crossover study ...
Show More Location
Chonbuk National University Hospital
Learn More & Join Trial